AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

OCI N.V.

Quarterly Report Aug 27, 2020

3869_ir_2020-08-27-113400_7c695886-6140-4935-b6d6-4c02e96f680f.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

OCI N.V.

Semi-annual condensed consolidated financial statements

For the six month period ended 30 June 2020

(unaudited)

OCI N.V. Annual Report 2019 1

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT

\$ millions Note 30 June
2020
31 December
2019
Assets
Non-current assets
Property, plant and equipment 6,357.4 6,570.6
Right-of-use assets 268.8 277.5
Goodwill and other intangible assets (8) 484.0 599.8
Trade and other receivables 4.1 4.1
Equity-accounted investees 476.8 506.9
Financial assets at fair value through other comprehensive income 29.4 33.4
Deferred tax assets 1.8 6.5
Total non-current assets 7,622.3 7,998.8
Current assets
Inventories 244.2 308.7
Trade and other receivables 448.2 508.4
Income tax receivables 2.3 3.2
Cash and cash equivalents 645.1 600.5
Total current assets 1,339.8 1,420.8
Total assets 8,962.1 9,419.6

CONSOLIDATED STATEMENT OF FINANCIAL POSITION CONTINUED AS AT

\$ millions Note 30 June
2020
31 December
2019
Equity
Share capital 5.6 5.6
Share premium 6,316.3 6,316.3
Reserves (253.1) (237.8)
Retained earnings (4,761.9) (4,726.6)
Equity attributable to owners of the Company 1,306.9 1,357.5
Non-controlling interest 1,433.1 1,461.2
Total equity 2,740.0 2,818.7
Liabilities
Non-current liabilities
Loans and borrowings (9) 4,281.9 4,392.7
Lease obligations 237.1 244.3
Trade and other payables 28.5 30.7
Provisions 2.9 2.8
Deferred tax liabilities 483.9 490.2
Total non-current liabilities 5,034.3 5,160.7
Current liabilities
Loans and borrowings (9) 202.9 269.6
Lease obligations 40.7 41.0
Trade and other payables 810.4 991.3
Provisions 128.4 129.5
Income tax payables 5.4 8.8
Total current liabilities 1,187.8 1,440.2
Total liabilities 6,222.1 6,600.9
Total equity and liabilities 8,962.1 9,419.6

CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

\$ millions Note Three month
period ended
30 June 2020
Three month
period ended
30 June 2019
Six month
period ended
30 June 2020
Six month
period ended
30 June 2019
Revenue
Cost of sales
(12)
(10)
875.4
(748.7)
953.5
(788.1)
1,686.5
(1,482.5)
1,550.0
(1,332.1)
Gross profit 126.7 165.4 204.0 217.9
Other income (0.4) (0.5) 13.4 2.8
Selling, general and administrative expenses (10) (52.1) (51.9) (109.2) (98.5)
Other expenses (0.3) (2.9) (0.3) (3.2)
Operating profit 73.9 110.1 107.9 119.0
Finance income (11) (4.1) (2.1) 31.9 17.1
Finance cost (11) (41.7) (64.2) (142.7) (174.9)
Net finance cost (11) (45.8) (66.3) (110.8) (157.8)
Income from equity-accounted investees (net of tax) (20.1) 1.8 (27.4) (7.9)
Profit / (loss) before income tax 8.0 45.6 (30.3) (46.7)
Income tax (6.2) (6.0) (3.4) 4.1
Total net profit / (loss) 1.8 39.6 (33.7) (42.6)
Other comprehensive income:
Items that are or may be reclassified subsequently to profit or loss
Movement in hedge reserve 0.8 (18.2) 0.6 (18.6)
Currency translation differences (50.0) (16.6) (47.6) (4.7)
Currency translation differences from equity-accounted investees (0.2) 0.1 (0.5) (0.1)
Items that will not be reclassified to profit or loss
Changes in the fair value of financial assets at fair value through other comprehensive income (1.1) (4.4) (3.5) (4.4)
Other comprehensive income, net of tax (50.5) (39.1) (51.0) (27.8)
Total comprehensive income (48.7) 0.5 (84.7) (70.4)
Profit / (loss) attributable to:
Owners of the Company (2.4) 19.9 (83.8) (61.3)
Non-controlling interest 4.2 19.7 50.1 18.7
Net profit / (loss) 1.8 39.6 (33.7) (42.6)
Total comprehensive income attributable to:
Owners of the Company (37.7) (19.2) (102.7) (85.5)
Non-controlling interest (11.0) 19.7 18.0 15.1
Total comprehensive income (48.7) 0.5 (84.7) (70.4)
(Loss) / earnings per share (in USD)
Basic (loss) / earnings per share (0.011) 0.095 (0.400) (0.293)
Diluted (loss) / earnings per share (0.011) 0.095 (0.400) (0.293)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Equity attributable
\$ millions Share capital Share premium Reserves Retained
earnings
to owners of the
Company
Non-controlling
interest
Total
equity
Balance at 1 January 2019 5.6 6,316.3 (249.0) (5,065.6) 1,007.3 469.8 1,477.1
Net profit / (loss) - - - (61.3) (61.3) 18.7 (42.6)
Other comprehensive income - - (24.2) - (24.2) (3.6) (27.8)
Total comprehensive income - - (24.2) (61.3) (85.5) 15.1 (70.4)
Impact difference in profit sharing non-controlling interest - - - - - 5.2 5.2
Dividend to non-controlling interest - - - - - (6.1) (6.1)
Treasury shares sold / delivered - - 3.9 (1.6) 2.3 - 2.3
Share-based payments - - - 2.8 2.8 - 2.8
Balance at 30 June 2019 5.6 6,316.3 (269.3) (5,125.7) 926.9 484.0 1,410.9
Balance at 1 January 2020 5.6 6,316.3 (237.8) (4,726.6) 1,357.5 1,461.2 2,818.7
Net profit / (loss) - - - (83.8) (83.8) 50.1 (33.7)
Other comprehensive income - - (18.9) - (18.9) (32.1) (51.0)
Total comprehensive income - - (18.9) (83.8) (102.7) 18.0 (84.7)
Impact difference in profit sharing non-controlling interest - - - - - 13.5 13.5
Treasury shares sold / delivered - - 3.6 (3.6) - - -
Business combination Fertiglobe - - - 48.3 48.3 (59.6) (11.3)
Share-based payments - - - 3.8 3.8 - 3.8
Balance at 30 June 2020 5.6 6,316.3 (253.1) (4,761.9) 1,306.9 1,433.1 2,740.0

CONSOLIDATED STATEMENT OF CASH FLOWS

\$ millions Note Three month
period ended
30 June 2020
Three month
period ended
30 June 2019
Six month
period ended
30 June 2020
Six month
period ended
30 June 2019
Net profit / (loss) 1.8 39.6 (33.7) (42.6)
Adjustments for:
Depreciation and amortization 147.5 111.5 289.6 224.8
Interest income (1.0) (1.4) (2.6) (3.1)
Interest expense 71.5 71.0 123.5 150.4
Net foreign exchange loss and others (24.7) (3.3) (10.1) 10.5
Share in income of equity-accounted investees 20.1 (1.8) 27.4 7.9
Fertiglobe business combination - - (13.3) -
Equity-settled share-based payment transactions 2.1 4.2 3.8 5.1
Impact difference in profit-sharing non-controlling interest 2.8 5.4 13.5 5.2
Income tax expense 6.2 6.0 3.4 (4.1)
Changes in:
Inventories 68.0 121.5 59.4 (10.3)
Trade and other receivables 132.0 (46.5) 25.4 85.5
Trade and other payables (74.0) 13.2 (81.2) (55.3)
Provisions 1.4 1.4 0.5 2.2
Cash flows:
Interest paid (115.7) (103.9) (156.5) (151.9)
Interest received 0.4 0.8 1.6 2.0
Income taxes paid (2.1) (39.5) (7.4) (40.0)
Cash flow from / (used in) operating activities 236.3 178.2 243.3 186.3
Investments in property, plant and equipment (68.1) (48.7) (163.8) (108.4)
Dividends from equity-accounted investees 2.6 1.4 2.6 1.6
Cash flow from / (used in) investing activities (65.5) (47.3) (161.2) (106.8)

CONSOLIDATED STATEMENT OF CASH FLOWS CONTINUED

\$ millions Note Three month
period ended
30 June 2020
Three month
period ended
30 June 2019
Six month
period ended
30 June 2020
Six month
period ended
30 June 2019
Proceeds from borrowings 48.0 12.2 512.3 219.7
Repayment of borrowings (521.7) (168.5) (660.4) (264.9)
Payment of lease obligations (15.2) (6.7) (24.1) (14.4)
Transaction costs (2.0) (2.0) (5.6) (2.0)
Post closing adjustment Fertiglobe - - 166.8 -
Cash flows from / (used in) financing activities (490.9) (165.0) (11.0) (61.6)
Net cash flows from / (used in) (320.1) (34.1) 71.1 17.9
Net increase / (decrease) in cash and cash equivalents (320.1) (34.1) 71.1 17.9
Cash and cash equivalents at start of period 974.5 509.7 600.5 460.7
Effect of exchange rate fluctuations on cash held (9.3) 1.9 (26.5) (1.1)
Cash and cash equivalents at 30 June 645.1 477.5 645.1 477.5

1. General

OCI N.V. ('OCI' or 'Company') was established on 2 January 2013 as a public limited liability company incorporated under Dutch law, with its head office located at Honthorststraat 19, Amsterdam, the Netherlands. OCI is registered in the Dutch commercial register under no. 56821166 dated 2 January 2013. The quarterly condensed consolidated financial statements comprise the financial statements of the Company, its subsidiaries (together referred to as the 'Group') and the Group's interests in associates and joint ventures.

The Group is primarily involved in the production of natural gas-based products.

2. Basis of preparation

2.1 General

The semi-annual condensed consolidated financial statements for the period ended 30 June 2020 have been prepared in accordance with IAS 34 'Interim Financial Reporting' and do not include all the information and disclosures required in the annual financial statements. Selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last annual consolidated financial statements as at and for the year ended 31 December 2019. The semi-annual condensed consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended 31 December 2019 which have been prepared in accordance with IFRS, as adopted by the European Union.

2.2 Fertiglobe business combination

On 30 September 2019, the Group and Abu Dhabi National Oil Company ("ADNOC") completed a transaction to combine ADNOC's fertilizer business into OCI's Middle East and North Africa ("OCI MENA") nitrogen fertilizer platform.

As part of the transaction, Fertiglobe, a subsidiary of the Group obtained OCI MENA under common control and 100% of the voting powers and economic returns from Ruwais Fertilizer Industries Ltd. ("Fertil"), a previously wholly owned subsidiary of ADNOC ('Combination'). Fertil has been consolidated by the Group from 30 September 2019. Fertil is based out of the Emirate of Abu Dhabi, United Arab Emirates and is engaged in processing feedstock gas to produce nitrogen fertilizers. In exchange, the Group transferred 42% of the total share capital of Fertiglobe to ADNOC. With the acquisition of Fertil, Fertiglobe will become the largest producer of nitrogen fertilizers in the MENA region.

The accounting for this business combination has been disclosed in our 2019 consolidated financial statements. As previously disclosed the accounting for this business combination at the end of 2019 was still provisional in respect of the accounting for the net debt settlement ('post-closing adjustment'). On 31 March 2020 the Company signed a final settlement with ADNOC for the post-closing adjustment which is considered to be an adjustment to the consideration transferred in this transaction. In our 2019 consolidated financial statements a settlement receivable was included of USD 49.7 million (which represented the uncontested amount at the time). In the final settlement a compensation of USD 178.0 million has been agreed with ADNOC as post-closing adjustment (of which USD 166.8 million was received in cash).

The measurement period adjustments recognized, compared to the 2019 consolidated financial statements, resulted in a decrease of goodwill (USD 115.1 million), trade and other receivables (USD 49.7 million) and non-controlling interest (USD 11.3 million) and an increase of cash (USD 166.8 million), which resulted in the identification of a gain on this transaction of USD 13.3 million.

Goodwill arising from the business combination has been recognized as follows:

\$ millions
Consideration transferred 1,057.5
NCI, based on their proportionate interest in the recognized amounts of the assets and
liabilities
710.6
Fair value of identifiable net assets (1,603.4)
Additional consideration received (178.0)
Gain on transaction* (13.3)

* Due to the final post-completion settlement between the Company and ADNOC, the total consideration transferred (USD1,590.1m) is less than the fair value of the identifiable net assets (USD1,603.4m), resulting in a gain on purchase of USD13.3m which is recorded in the profit or loss.

2.3 Covid-19 impact

The outbreak of Covid-19 continues to impact the global economy and markets. Due to its pivotal role in the global food production, our business operations have been designated in all jurisdictions where we produce as critical infrastructure by the respective governments and all our product are deemed as essential by governments to ensure uninterrupted supply of goods and other essential products. At this time, the impact of the outbreak on our business has been limited as production at our plants is uninterrupted, and we have not witnessed significant changes in demand and have continued to ship products to our customers without experiencing any significant delay in ship, rail or truck transportation services due to the Covid-19. We noted decreasing selling prices for all our products over the course of the second quarter of 2020. As global energy prices plummeted, driving higher global operating rates and resulting in additional supply. Although based on the recent market recovery, we expect this will not impact the long term outlook of our business and the valuation of our assets.

We established an internal Covid-19 taskforce, to ensure safety of our employees and business continuity. OCI applied strict protective measures, including sanitation, personal protection equipment, social distancing and thermal testing prior to accessing any group locations and the status of returning to workplace differs per jurisdiction. Currently the majority of the locations are now at 50%-70% employee occupancy rates. As our plants are heavily automated, essential on-site operating and logistics personnel can be limited and administrative and operational support personnel have worked remotely in order to maintain social distancing following governmental guidelines.

Although the long term effects of Covid-19 are still unclear, our current outlook is that our financial and operating performance remains solid. We have operated our business in a remote working environment and could continue to do so for an extended period, if necessary. Developments in each jurisdiction are being closely monitored and protocols are flexible to allow for rapid adjustments as needed, particularly given the risk of a second wave at many of our jurisdictions. The impressive resilience of our staff throughout the period gives all local management teams confidence to revert to a work-from-home policy again, if their locations face a second wave without interruptions to our operations and supply chain.

3. Summary of significant accounting policies

The accounting policies applied over the six month period ended 30 June 2020 are consistent with those applied in the consolidated financial statements for the year ended 31 December 2019. The Group has not early adopted any other standard, interpretation or amendment that has been issued but is not yet effective.

IFRS standards and interpretations thereof not yet in force which may apply to the future Group's consolidated financial statements are being assessed for their potential impact. Currently there are no standards and interpretations not yet effective that would have a significant impact on the Group.

4. Seasonality of operations

Our product portfolio is diversified primarily by industry and geography. The nitrogen fertilizer industry is inherently dependent on fundamental supply and demand drivers, including global population growth, crop yields, feedstock costs, and seasonality of crop planting and harvesting seasons. These and other long-term and short-term drivers result in cyclical nitrogen fertilizer pricing trends. Supply and demand dynamics in the industrial chemicals industries in which we operate, including industrial ammonia, methanol, and melamine, are more evenly distributed throughout the year, thereby contributing to stability in sales volumes. The global sales and diversified product mix - both as fertilizers and chemical products - mitigate the impact of any one product or region's seasonal fluctuations.

5. Critical accounting judgment, estimates and assumptions

The preparation of the financial statements in compliance with IFRS requires management to make judgements, estimates and assumptions that affect amounts reported in the condensed consolidated financial statements. The estimates and assumptions are based on experience and various other factors that are believed to be reasonable under the circumstances and are used to judge the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised or in the revision period and future periods, if the changed estimates affect both current and future periods.

Compared to the consolidated financial statements for the year ended 31 December 2019 there were no significant changes to the critical accounting judgements, estimates and assumptions that could result in significantly different amounts than those recognized in the financial statements. As a result of the outbreak of Covid-19 in 2020, all our critical accounting judgments, estimates and assumptions

have been reviewed and updated when necessary following this situation.

With respect to financial instruments, there has not been any reclassification between categories of financial instruments compared to the consolidated financial statements for the year ended 31 December 2019. The objectives and policies of financial risk and capital management are consistent with those disclosed in the consolidated financial statements for the year ended 31 December 2019.

6. Significant rates

The following significant exchange rates applied during the period:

Average during the
six month period
ended 30 June 2020
Average during the
six month period
ended 30 June 2019
Closing as at
30 June 2020
Closing as at 31
December 2019
Euro 1.1019 1.1317 1.1243 1.1213
Egyptian pound 0.0632 0.0579 0.0619 0.0623
Algerian dinar 0.0081 0.0084 0.0077 0.0084

7. Financial risk and capital management

7.1 Financial risk management

Categories of financial instruments:

30 June 2020
\$ millions
Loans and
receivables /
payables at
amortized cost
Derivatives
at fair value
Financial assets
through other
comprehensive income
at fair value
Assets
Trade and other receivables 445.4 6.9 -
Financial assets at fair value through
other comprehensive income
- - 29.4
Cash and cash equivalents 645.1 - -
Total 1,090.5 6.9 29.4
Liabilities
Loans and borrowings 4,484.8 - -
Trade and other payables 821.2 17.7 -
Total 5,306.0 17.7 -
31 December 2019
\$ millions
Loans and
receivables /
payables at
amortized cost
Derivatives
at fair value
Financial assets
through other
comprehensive
income at fair
value
Assets
Trade and other receivables 507.5 5.0 -
Financial assets at fair value through
other comprehensive income
- - 33.4
Cash and cash equivalents 600.5 - -
Total 1,108.0 5.0 33.4
Liabilities
Loans and borrowings 4,662.3 - -
Trade and other payables 1,004.4 17.6 -
Total 5,666.7 17.6 -

The Group has limited financial instruments carried at fair value. For derivative financial instruments, the fair value is calculated within hierarchy category level 2. Financial assets at fair value through other comprehensive income recognized as level 1 is USD 2.9 million (2019: USD 3.4 million), the investment in the Infrastructure and Growth Capital Fund of USD 4.7 million (2019: USD 6.8 million) was recognized as level 2 as the valuation is partially derived from listed shares. The investment in Notore Chemical of USD 21.8 million (2019: USD 23.2 million) is recognized as level 3.

Notore was listed on the Nigerian Stock Exchange in 2018, however due to the lack in trading volumes the investment is still valued within the hierarchy category level 3 based on audited financial statements.

In 2020 and 2019, there were no transfers between the fair value hierarchy categories. The carrying amounts of financial assets and liabilities carried at amortized cost (loans and borrowings, trade and other receivables and trade and other payables) approximates their fair values.

7.2 Capital management

The Board's policy is to maintain a strong capital base so as to maintain investor, creditor and market confidence and to sustain future development of the business. Capital consists of ordinary shares, retained earnings and non-controlling interest of the Group. The Board of Directors monitors the return on capital as well as the level of dividends to ordinary shareholders. The Group is required by external financial institutions to maintain certain capital requirements compared to its debt.

The Group's net debt to equity ratio at the reporting date was as follows:

\$ millions 30 June
2020
31 December
2019
Loans and borrowings 4,484.8 4,662.3
Less: cash and cash equivalents 645.1 600.5
Net debt 3,839.7 4,061.8
Total equity 2,740.0 2,818.7
Net debt to equity ratio at 1.40 1.44

8. Goodwill and other intangible assets

No impairment test was performed on goodwill in the period, as no impairment triggers were identified. The annual goodwill impairment test will be performed in the fourth quarter.

9. Loans and borrowings

\$ millions 30 June
2020
31 December
2019
At 1 January 4,662.3 4,580.3
Proceeds from loans 512.3 1,765.5
Redemptions of loans (660.4) (1,654.4)
Newly incurred transaction costs - (24.1)
Amortization of transaction costs / (bond) premiums 8.5 25.6
Effect of movement in exchange rates (37.9) (24.4)
Debt modification gain - (6.2)
Balance at 4,484.8 4,662.3
Non-current 4,281.9 4,392.7
Current 202.9 269.6
Total 4,484.8 4,662.3

The effect of movement in exchange rate mainly relates to EUR and DZD denominated loans, which are different from the Group's presentation currency.

New and amended financing arrangements in Q2 2020

There are no new or amended financing arrengements.

Covenants

Certain loan agreements include financial covenants. As per 30 June 2020 all financial covenants were met. In the event the respective borrowing company's would not comply with the covenant requirements, its loans would become immediately due. The external borrowings include change in control clauses that enable the lenders to call the financing provided.

10. Development of cost of sales and selling, general and administrative expenses

12. Segment reporting

Expenses by nature

\$ millions 30 June
2020
30 June
2019
Raw materials and consumables and finished goods 1,022.3 977.7
Maintenance and repair 56.3 52.5
Employee benefit expenses 177.5 129.3
Depreciation and amortization 289.6 224.8
Consultancy expenses 15.3 13.3
Other 30.7 33.0
Total 1,591.7 1,430.6
Cost of sales 1,482.5 1,332.1
Selling, general and administrative expenses 109.2 98.5
Total 1,591.7 1,430.6

11. Net finance cost

\$ millions 30 June
2020
30 June
2019
Interest income on loans and receivables 2.6 3.1
Foreign exchange gain 29.3 14.0
Finance income 31.9 17.1
Interest expense and other financing costs on financial liabilities measured
at amortized cost
(118.3) (147.9)
Interest expense lease liabilities (IFRS 16) (5.2) (2.4)
Foreign exchange loss (19.2) (24.6)
Finance cost (142.7) (174.9)
Net finance cost recognized in profit or loss (110.8) (157.8)

The foreign exchange gains and losses mainly relate to external financing and to the revaluation of intercompany balances in foreign currencies (for which the statement of profit or loss impact is not eliminated in the consolidated financial statements).

30 June 2020
\$ millions
Methanol
US1
Methanol
Europe
Nitrogen
US
Nitrogen
Europe
Fertiglobe Other Eliminations Total
Total revenues 227.9 130.8 284.0 392.3 737.5 0.7 (86.7) 1,686.5
EBITDA2 52.6 7.8 99.2 78.9 205.6 (19.5) (27.1) 397.5
Adjusted EBITDA2 50.2 7.8 99.2 78.9 209.1 (30.2) (2.5) 412.5
Income from equity
accounted investees
- - - 2.0 - 0.6 (30.0) (27.4)
Depreciation and
amortization
(70.0) (12.4) (70.3) (39.5) (133.6) (2.0) 38.2 (289.6)
Finance income 0.4 - 0.2 4.2 21.7 61.3 (55.9) 31.9
Finance expense (17.7) (1.8) (63.7) (5.2) (37.8) (88.9) 72.4 (142.7)
Income tax
(expense) / income
1.2 (0.1) (0.1) (10.4) (11.5) 17.5 - (3.4)
Net profit / (loss) (33.5) (6.5) (34.7) 30.0 44.4 (31.0) (2.4) (33.7)
Equity-accounted
investees
- - - 14.5 - 0.5 461.8 476.8
Capital expenditures
PP&E
46.0 30.8 1.6 31.6 24.3 0.3 (5.6) 129.0
Total assets 1,551.9 385.0 2,166.7 678.5 4,616.7 132.5 (569.2) 8,962.1

1 Including ammonia at OCIB

2 OCI N.V. uses Alternative Performance Measures ('APM') to provide a better understanding of the underlying developments of the performance of the business. The APMs are not defined in IFRS and should be used as supplementary information in conjunction with the most directly comparable IFRS measures.

12. Segment reporting (continued)

30 June 2019
\$ millions
Methanol
US1
Methanol
Europe
Nitrogen
US
Nitrogen
Europe
Fertiglobe Other Eliminations Total
Total revenues 297.6 122.9 302.2 466.4 467.0 - (106.1) 1,550.0
EBITDA2 64.1 (7.0) 127.2 77.9 167.6 (44.6) (41.4) 343.8
Adjusted EBITDA2 72.4 (6.0) 127.2 79.8 167.6 (35.4) (1.2) 404.4
Income from equity (0.7) - - 2.6 - - (9.8) (7.9)
accounted investees
Depreciation and
amortization
(63.2) (5.2) (66.3) (33.8) (87.6) (2.2) 33.5 (224.8)
Finance income 0.2 - 0.4 2.0 7.6 64.7 (57.8) 17.1
Finance expense (35.3) 0.3 (54.7) (3.9) (81.3) (76.3) 76.3 (174.9)
Income tax income / 0.4 (1.1) (0.8) (11.0) (5.2) 21.8 - 4.1
(expense)
Net (loss) / profit (34.5) (13.0) 5.8 33.8 1.1 (36.6) 0.8 (42.6)
Equity-accounted
investees - - - 14.6 - 0.7 540.4 555.7
Capital expenditures
PP&E 12.1 46.5 9.5 47.7 6.4 0.6 (1.0) 121.8
Total assets 1,738.4 366.3 2,293.5 703.4 2,753.0 105.5 (627.5) 7,332.6

1 Including ammonia at OCIB

2 OCI N.V. uses Alternative Performance Measures ('APM') to provide a better understanding of the underlying developments of the performance of the business. The APMs are not defined in IFRS and should be used as supplementary information in conjunction with the most directly comparable IFRS measures.

Until 2019 OCI Fuels Ltd. was included in segment Methanol US. Effective 1 January 2020, OCI Fuels Ltd. will be combined with OCI Fuels B.V. in the segment Methanol Europe. The comparative numbers of 2019 are restated to reflect that change.

13. Contingencies

There have been no significant changes in contingencies compared to the situation as described in the consolidated financial statements for the year ended 31 December 2019.

14. Subsequent events

None.

DIRECTORS' RESPONSIBILITY STATEMENT

In accordance with Article 5:25d of the Dutch Financial Supervision Act, the members of the board of directors of OCI N.V. declare that, to the best of their knowledge, the semi-annual condensed consolidated financial statements included in this semi-annual report, which have been prepared in accordance with IAS 34 'Interim Financial Reporting', give a true and fair view of OCI N.V.'s assets, liabilities, financial position and profit or loss of OCI N.V. and its consolidated group companies taken as a whole and the half-year press release attached to this semi-annual report gives a fair view of the information required pursuant to section 5:25d (8)/(9) of the Dutch Financial Supervision Act.

Amsterdam, the Netherlands, 26 August 2020

The OCI N.V. Board of Directors

Talk to a Data Expert

Have a question? We'll get back to you promptly.